Search details
1.
Impact of young age on platinum response in women with epithelial ovarian cancer: Results of a large single-institution registry.
Gynecol Oncol
; 160(1): 77-82, 2021 01.
Article
in English
| MEDLINE | ID: mdl-33059915
2.
Optimizing Local Control in High-Grade Uterine Sarcoma: Adjuvant Vaginal Vault Brachytherapy as Part of a Multimodal Treatment.
Oncologist
; 22(2): 182-188, 2017 02.
Article
in English
| MEDLINE | ID: mdl-28174295
3.
Prognostic significance of an early decline in serum alpha-fetoprotein during chemotherapy for ovarian yolk sac tumors.
Gynecol Oncol
; 142(3): 452-7, 2016 09.
Article
in English
| MEDLINE | ID: mdl-27401840
4.
Final results of a phase 3 study of trebananib plus weekly paclitaxel in recurrent ovarian cancer (TRINOVA-1): Long-term survival, impact of ascites, and progression-free survival-2.
Gynecol Oncol
; 143(1): 27-34, 2016 Oct.
Article
in English
| MEDLINE | ID: mdl-27546885
5.
A Phase I Trial of High-Dose Chemotherapy Combining Topotecan plus Cyclophosphamide with Hematopoietic Stem Cell Transplantation for Ovarian Cancer: The ITOV 01bis Study.
Chemotherapy
; 61(1): 15-22, 2016.
Article
in English
| MEDLINE | ID: mdl-26528705
6.
Surgical Outcomes After Debulking Surgery for Intraabdominal Ovarian Growing Teratoma Syndrome: Analysis of 38 Cases.
Ann Surg Oncol
; 22 Suppl 3: S964-70, 2015 Dec.
Article
in English
| MEDLINE | ID: mdl-26033179
7.
Multimodal treatment with doxorubicin, cisplatin, and ifosfamide for the treatment of advanced or metastatic uterine leiomyosarcoma: a unicentric experience.
Int J Gynecol Cancer
; 25(2): 296-302, 2015 Feb.
Article
in English
| MEDLINE | ID: mdl-25581897
8.
Anti-angiopoietin therapy with trebananib for recurrent ovarian cancer (TRINOVA-1): a randomised, multicentre, double-blind, placebo-controlled phase 3 trial.
Lancet Oncol
; 15(8): 799-808, 2014 Jul.
Article
in English
| MEDLINE | ID: mdl-24950985
9.
Adjuvant platinum-based chemotherapy for borderline serous ovarian tumors with invasive implants.
Gynecol Oncol
; 132(1): 23-7, 2014 Jan.
Article
in English
| MEDLINE | ID: mdl-24219980
10.
Gynecologic Cancer InterGroup (GCIG) consensus review for ovarian tumors of low malignant potential (borderline ovarian tumors).
Int J Gynecol Cancer
; 24(9 Suppl 3): S5-8, 2014 Nov.
Article
in English
| MEDLINE | ID: mdl-25341581
11.
A randomized phase II trial of maintenance therapy with Sorafenib in front-line ovarian carcinoma.
Gynecol Oncol
; 130(1): 25-30, 2013 Jul.
Article
in English
| MEDLINE | ID: mdl-23591401
12.
Sentinel lymph node in endometrial cancer: a review.
Curr Oncol Rep
; 15(6): 559-65, 2013 Dec.
Article
in English
| MEDLINE | ID: mdl-24190831
13.
Lymphocele and ovarian cancer: risk factors and impact on survival.
Oncologist
; 17(9): 1198-203, 2012.
Article
in English
| MEDLINE | ID: mdl-22707515
14.
Prognosis and prognostic factors of the micropapillary pattern in patients treated for stage II and III serous borderline tumors of the ovary.
Oncologist
; 16(2): 189-96, 2011.
Article
in English
| MEDLINE | ID: mdl-21273510
15.
Prognostic factors of a large retrospective series of mucinous borderline tumors of the ovary (excluding peritoneal pseudomyxoma).
Ann Surg Oncol
; 18(1): 40-8, 2011 Jan.
Article
in English
| MEDLINE | ID: mdl-20737216
16.
Fertility determinants after conservative surgery for mucinous borderline tumours of the ovary (excluding peritoneal pseudomyxoma).
Hum Reprod
; 26(4): 808-14, 2011 Apr.
Article
in English
| MEDLINE | ID: mdl-21262776
17.
Prognostic value of lymph node involvement in ovarian serous borderline tumors.
Am J Obstet Gynecol
; 204(5): 438.e1-7, 2011 May.
Article
in English
| MEDLINE | ID: mdl-21349494
18.
Prognostic factors and morbidities after completion surgery in patients undergoing initial chemoradiation therapy for locally advanced cervical cancer.
Oncologist
; 15(4): 405-15, 2010.
Article
in English
| MEDLINE | ID: mdl-20332143
19.
Phase II study of gefitinib in combination with paclitaxel (P) and carboplatin (C) as second-line therapy for ovarian, tubal or peritoneal adenocarcinoma (1839IL/0074).
Gynecol Oncol
; 116(2): 157-62, 2010 Feb.
Article
in English
| MEDLINE | ID: mdl-20109725
20.
Correlation between macroscopic and microscopic diseases on splenectomies performed in the surgical management of ovarian cancer.
Int J Gynecol Cancer
; 20(6): 965-70, 2010 Aug.
Article
in English
| MEDLINE | ID: mdl-20683403